Effects of Triflusal and Clopidogrel in Secondary Prevention of Stroke Based on Cytochrome P450 2C19 Genotyping

被引：0
|
作者：
Lee, Kyung-Yul
Han, Sang Won
Kim, Yong-Jae
Ahn, Seong Hwan
Seo, Woo-Keun
Yu, Sungwook
Oh, Seung-Hun
Kim, Youn Nam
机构：
来源：
STROKE | 2017年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
ATP411
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Effects of Triflusal and Clopidogrel on the Secondary Prevention of Stroke Based on Cytochrome P450 2C19 Genotyping
    Han, Sang Won
    Kim, Yong-Jae
    Ahn, Seong Hwan
    Seo, Woo-Keun
    Yu, Sungwook
    Oh, Seung-Hun
    Nam, Hyo Suk
    Choi, Hye-Yeon
    Yoon, Sung Sang
    Kim, Seo Hyun
    Lee, Jong Yun
    Lee, Jun Hong
    Hwang, Yang-Ha
    Lee, Kee Ook
    Jung, Yo Han
    Lee, Jun
    Sohn, Sung-Il
    Kim, Youn Nam
    Lee, Kyung-A
    Bushnell, Cheryl D.
    Lee, Kyung-Yul
    JOURNAL OF STROKE, 2017, 19 (03) : 356 - +
  • [2] Cytochrome P450 2C19 genotyping for clopidogrel response - the state of play
    Dick, R. J.
    Byron, K. A.
    Dear, A. E.
    INTERNAL MEDICINE JOURNAL, 2012, 42 : 7 - 8
  • [3] Protocol for the comparison of triflusal and clopidogrel in secondary prevention of stroke based on cytochrome P450 2C19 genotyping (MASETRO study): A multicenter, randomized, open-label, parallel-group trial
    Han, Sang Won
    Kim, Yong-Jae
    Ahn, Seong Hwan
    Seo, Woo-Keun
    Yu, Sungwook
    Oh, Seung-Hun
    Kim, Youn Nam
    Lee, Kyung-Yul
    INTERNATIONAL JOURNAL OF STROKE, 2016, 11 (04) : 485 - 491
  • [4] Cytochrome P450 2C19 Genotypes and Clopidogrel in Patients With Ischemic Stroke
    Jung, Yo Han
    Song, Tae-Jin
    Kim, Jinkwon
    Park, Hee-Kwon
    Han, Sang Won
    Kim, Young Dae
    Park, Jong-Ho
    Cha, Jae-Kwan
    Park, Hyun Young
    Sohn, Sung-Il
    Yu, Sungwook
    Lee, Jun Hong
    Shin, Dong Hoon
    Kim, Eung-Gyu
    Lee, Hye Sun
    Lee, Kyung-Yul
    JAMA NETWORK OPEN, 2025, 8 (04)
  • [5] Cytochrome P450 2C19 polymorphism and clopidogrel after MI
    Bhattacharyya, Sanjeev
    Rakhit, Roby
    LANCET, 2009, 373 (9670): : 1171 - 1171
  • [6] The Pharmacogenetics of Cytochrome P450 2C19 enzymes - Effects on Clopidogrel and Proton Pump Inhibitors
    Liau, Yusmiati
    Muliaty, Dewi
    INDONESIAN BIOMEDICAL JOURNAL, 2014, 6 (01): : 33 - 44
  • [7] Human Cytochromes P450: Focus on Cytochrome P450 2C19
    Zvyaga, Tatyana
    Chang, Shu-Ying
    Chen, Cliff
    Yang, Zheng
    Vuppugalla, Ragini
    Hurley, Jeremy
    Thorndike, Denise
    Wagner, Andrew
    Chimalakonda, Anjaneya
    Rodrigues, A. David
    DRUG METABOLISM AND DISPOSITION, 2012, 40 (09) : 1698 - 1711
  • [8] Clopidogrel preventive effect based on cytochrome P450 2C19 genotype in ischaemic stroke: protocol for multicentre observational study
    Song, Tae-Jin
    Kim, Jinkwon
    Han, Sang Won
    Kim, Young Dae
    Lee, Jong Yun
    Ahn, Seong Hwan
    Lee, Hye Sun
    Jung, Yo Han
    Lee, Kyung-Yul
    BMJ OPEN, 2020, 10 (08):
  • [9] Cytochrome P450 2C19 Polymorphism is Associated with Reduced Clopidogrel Response in Cerebrovascular Disease
    Lee, Jun-Beom
    Lee, Kyung-A
    Lee, Kyung-Yul
    YONSEI MEDICAL JOURNAL, 2011, 52 (05) : 734 - 738
  • [10] Comparison of mechanism-based inhibition of human cytochrome P450 2C19 by ticlopidine, clopidogrel, and prasugrel
    Nishiya, Y.
    Hagihara, K.
    Kurihara, A.
    Okudaira, N.
    Farid, N. A.
    Okazaki, O.
    Ikeda, T.
    XENOBIOTICA, 2009, 39 (11) : 836 - 843
12345